Key result
ProSEL-Boost algorithm detects atherosclerosis with ~95% accuracy and flags glucose-lipid interaction as a potent biomarker.
Why the study?
Atherosclerotic disease detection requires models that are both accurate and clinically interpretable.
Does the ProSEL-Boost ensemble learning framework accurately detect atherosclerosis in clinical datasets?
Does the ProSEL-Boost ensemble learning framework accurately detect atherosclerosis in clinical datasets?
The ProSEL-Boost machine learning framework demonstrates high accuracy for atherosclerosis detection and identifies the glucose-lipid interaction index as a strong metabolic biomarker.
Hypothesis-generating for ML-based atherosclerosis detection; leaves open prospective validation before clinical adoption.
Atherosclerotic disease detection requires models that are both accurate and clinically interpretable. This study proposes a robust and interpretable ensemble learning framework to address this need. We introduce the Progressive Saturated Exponential Loss Adaptive Boosting (ProSEL-Boost) algorithm, which enhances robustness against noisy clinical data through a dynamic loss function with a saturation mechanism. Furthermore, we develop a medical knowledge-guided framework to generate biologically meaningful interaction features based on established pathophysiological pathways, alongside a multi-strategy ensemble method for feature selection. When evaluated on a public coronary artery disease dataset (n = 303) and a proprietary atherosclerosis dataset (n = 284; 37 cases, 247 controls), ProSEL-Boost achieved superior and balanced performance (accuracy = 0.9508, AUC = 0.8807). Crucially, our interpretable feature pipeline identified the glucose-lipid interaction index (TG_FBG_Index) as a potent biomarker (Cohen’s d = 1.97, AUC = 0.86), highlighting a synergistic metabolic risk factor. Given the modest sample size, particularly the limited number of positive cases, this study should be viewed primarily as a rigorous methodological validation and hypothesis-generating investigation. The framework provides a compelling rationale for, but does not replace, validation in larger prospective cohorts, offering a transparent methodology for improving early disease detection and generating actionable insights for risk stratification.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied Atherosclerosis and Coronary Artery Disease (n=587). ProSEL-Boost algorithm was evaluated on Atherosclerosis detection performance (accuracy and AUC) (Accuracy 0.9508, AUC 0.8807). The ProSEL-Boost algorithm achieved high performance for atherosclerosis detection (accuracy 0.9508, AUC 0.8807) and identified the glucose-lipid interaction index as a potent biomarker.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: